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Abstract Cytochrome c release from mitochondria is essential
for apoptosis. Using human myelogenous leukemia ML-1a, its
respiration-deficient and reconstituted cells, we demonstrated
that respiratory function is essential for tumor necrosis factor-
induced cytochrome c release. In a cell free system using
mitochondrial fraction from ML-1a, initiation of respiration by
substrates for complexes I, II, and III but not IV released
cytochrome c, suggesting that reduction of coenzyme Q or
complex III is essential for cytochrome c release. In the same
system, disruption of mitochondrial outer membrane was neither
enough nor the cause for cytochrome c release by succinate.
These observations define an early pathway in which a change in
respiration releases cytochrome c. ß 2001 Published by Else-
vier Science B.V. on behalf of the Federation of European Bio-
chemical Societies.
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1. Introduction
Changes in mitochondrial function are thought to be in-
volved in apoptosis induction. Several reports identi¢ed mol-
ecules in mitochondria that can activate downstream apopto-
sis signals. Cytochrome c is ¢rst described as one of such
molecules and released from mitochondria, which leads to
the activation of caspase 3 [1]. Cytochrome c released from
mitochondria forms a complex with Apaf-1 to catalyze the
activation of caspase 9 in a dATP-dependent manner [2]. Ac-
tivated caspase 9 cleaves and activates caspase 3 leading to
apoptosis. It is very likely that cytochrome c release from
mitochondria can induce apoptosis, however several other re-
ports imply di¡erent roles of cytochrome c in apoptosis sig-
naling [3,4]. Apoptosis-inducing factor [5], which can cause
nuclear condensation [6], is also released from mitochondria
under apoptotic conditions. Several reagents can open mito-
chondrial permeability transition pores, leading to a release of
apoptosis-inducing factor [7]. Other reports indicate the in-
volvement of mitochondrial caspases 2 and 9 in apoptotic
signaling [8]. These reports indicate that a change in mito-
chondria releases certain molecules, which are responsible
for apoptosis signaling.
It has been believed that caspase 8 directly activates caspase
3 [9,10]. However, several reports indicate the synergistic ac-
tion of caspase 8 and mitochondria to activate caspase 3 [11],
and the involvement of cytochrome c in caspase 8 activation
[12]. In Fas-induced apoptosis signaling, activation of caspase
8 can cleave bid to associate to mitochondria, which results in
cytochrome c release [13,14]. We and others showed that cy-
tochrome c release was observed prior to caspase 3 activation
in tumor necrosis factor (TNF) and UVB/staurosporine-in-
duced apoptosis signaling [15]. Therefore, it is likely that cy-
tochrome c release might be important prior to or at the same
time with the activation of caspase which is the critical event
in apoptosis signaling.
We have previously shown the requirements of mitochon-
drial respiratory function in TNF-induced apoptosis signaling
by using a panel of respiration-de¢cient clones and their re-
constituted cybrids with normal mitochondria [16]. Our study
placed mitochondrial respiratory function at a step prior to
the activation of a caspase 3-like protease in TNF-induced
apoptosis signaling. We also showed that an antioxidant-sen-
sitive pathway is involved prior to cytochrome c release in
TNF-induced apoptosis signaling [17]. Since reactive oxygen
species (ROS) are mainly generated dependent on mitochon-
drial respiration, and can induce cytochrome c release [18], the
antioxidant-sensitive pathway might be regulated by mito-
chondrial respiratory function.
In this paper, we investigated the role of respiratory func-
tion in cytochrome c release. We demonstrated that the elec-
tron transfer through mitochondrial respiratory chain (MRC)
complex II^III^IV is responsible for cytochrome c release by
TNF. We also showed that the reduction of MRC by speci¢c
MRC substrates could release cytochrome c in cell free sys-
tems.
2. Materials and methods
2.1. Establishment of respiration-de¢cient and reconstituted clones
Respiration-de¢cient and reconstituted clones were established and
maintained as described [16].
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2.2. DNA fragmentation assay
DNA fragmentation induced by TNF was assayed by the modi¢ed
method as described [19].
2.3. Respiration measurement
Oxygen consumption was measured with a Clark oxygen electrode
(model 5300; Yellow Spring Instrument Co., Yellow Spring, OH,
USA) as described [20].
2.4. Cytosolic fraction
After cells were washed with phosphate-bu¡ered saline, 20 Wl of
bu¡er (250 mM sucrose, 30 mM Tris, pH 7.7, 1 mM EDTA, 5%
glycerol, 1 WM PMSF, 1 Wg/ml leupeptin, 1 Wg/ml pepstatin, and
1 Wg/ml aprotinin) was added, and the cells were disrupted by dounc-
ing 80 times in a 0.3 ml Kontes douncer with the B pestle (Kontes
Glass Company). Under these conditions, most of the cell membrane
is damaged with no change in mitochondrial respiratory activity.
2.5. Mitochondrial fraction
0.5^2U108 ML-1a cells were suspended in 1 ml sucrose bu¡er
(250 mM sucrose, 30 mM Tris^HCl, pH 7.7) and the cell membrane
was disrupted by N2 cavitation (250 psi for 5 min). Under these
conditions, most of the cell membrane is damaged with no change
in mitochondrial respiratory activity. Next, DNA and nuclear were
removed by centrifugation (1500Ug, 30 s). Supernatant fraction was
centrifuged (16 000Ug, 10 min) and the pellet was suspended in su-
crose bu¡er and used as mitochondrial fraction. To investigate cyto-
chrome c release and oxygen consumption, 2 mM KH2PO4, 1 mM
ADP and an indicated amount of substrate for MRC complexes were
added to initiate state 3 respiration.
2.6. Detection of cytochrome c release from mitochondrial fraction
by Western blotting
Detection of cytochrome c release was done by Western blotting
analysis as described previously [17].
2.7. Flow cytometry of mitochondrial fraction
Detection of outer membrane disruption by anti-cytochrome c oxi-
dase was assayed by the modi¢ed method as described [21].
Fig. 1. A: Time-dependent induction of apoptosis by TNF and CHX in ML-1a and clone 19. B: Dose-dependent induction of apoptosis by
TNF in ML-1a, clone 19 and P1 in the presence of CHX. A: [3H]TdR prelabeled ML-1a (left) or clone 19 (right) were incubated with or with-
out 1 nM TNF in the presence or absence of 1 Wg/ml CHX for indicated times, and fragmented DNA was determined as described in Section
2. B: [3H]TdR prelabeled ML-1a, clone 19 and P1 were incubated with an indicated amount of TNF in the presence of 1 Wg/ml CHX for
90 min, and fragmented DNA was determined as described in Section 2.
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3. Results and discussions
To investigate whether respiratory function is necessary for
apoptosis signaling, especially cytochrome c release, which
leads to caspase 3 activation, we used ML-1a, respiration-
de¢cient clone 19, and the reconstituted clone P1. Respira-
tion-dependent changes in electron transfer in the MRC might
be inhibited in respiration-de¢cient cells and recovered in re-
constituted clone. Fig. 1A shows the time-dependent e¡ect of
TNF, protein synthesis inhibitor cycloheximide (CHX) and
both of TNF and CHX in ML-1a (left) and in clone 19
(right). In ML-1a, TNF in the presence of CHX showed a
very strong apoptosis-inducing e¡ect. However, CHX or TNF
alone showed very little e¡ect. In contrast, even TNF in the
presence of CHX had no e¡ect in clone 19. We also tested the
dose-dependent e¡ect of TNF in the presence of CHX on
ML-1a, clone 19 and reconstituted clone P1 (Fig. 1B). The
apoptosis-inducing e¡ect of TNF was completely inhibited in
clone 19 and recovered in P1.
Next, we investigated cytochrome c release. ML-1a, clone
19, and P1 were treated with TNF and CHX for 90 min, and
tested for their e¡ect on cytochrome c release from mitochon-
dria (Fig. 2A). TNF in the presence of CHX could release
cytochrome c in ML-1a cells. However, we could not observe
an increase in TNF-induced cytochrome c release in clone 19.
Furthermore, an increase in cytochrome c release by TNF was
also observed in clone P1. TNF or CHX alone had little e¡ect
on releasing cytochrome c in ML-1a [17]. These results suggest
that respiratory function is involved prior to cytochrome c
release in TNF-induced apoptosis.
MRC is composed of ¢ve enzyme complexes: NADH: ubi-
quinone oxidoreductase (complex I), succinate: ubiquinone
oxidoreductase (complex II), ubiquinone: ferricytochrome c
oxidoreductase (complex III), ferrocytochrome c : oxygen oxi-
doreductase (complex IV), and F0F1-ATPase (complex V).
Complexes I, II, III, and IV plus coenzyme Q and cytochrome
c make up the MRC and complex V generates ATP by cou-
pling with the membrane potential generated at complexes I,
III, and IV. Several reports imply that inhibition of complexes
I and III can induce apoptosis [22,23] possibly through the
regulation of the redox state of mitochondria and the gener-
ation of ROS. We previously showed that inhibition of com-
plex I by TNF can release cytochrome c in the presence of
protein synthesis inhibitor CHX through an antioxidant-sen-
sitive fashion [17]. Therefore, we investigated the role of elec-
tron transfer on cytochrome c release. To investigate whether
electron transfer in the MRC might be involved in TNF-in-
duced apoptosis, we tested the ability of inhibitors of com-
plexes I and II (the entrances of electrons to MRC) to inhibit
TNF-induced cytochrome c release. Thenoyltri£uoroacetate
(TTFA), an inhibitor of complex II, may inhibit electron
£ow through complex II^III^IV, and rotenone, an inhibitor
of complex I, may inhibit electron £ow through complex
I^III^IV. We previously showed that rotenone in the presence
of CHX induced apoptosis and cytochrome c release, but
rotenone alone showed very little e¡ect on apoptosis induc-
tion and cytochrome c release [17]. Now we con¢rmed that
rotenone alone as well as TTFA had no e¡ect on cytochrome
c release. TTFA inhibited cytochrome c release induced by
TNF plus CHX in vivo, but rotenone increased cytochrome
c release induced by TNF plus CHX, suggesting that electron
£ow through complex II^III^IV might be essential in cyto-
chrome c release induced by TNF plus CHX (Fig. 2B).
Although we used the speci¢c inhibitors of complexes I and
II, other non-speci¢c action needs to be considered. Espe-
cially, since TTFA can work as a chelating reagent, it might
work as an antioxidant.
To further investigate the roles of electron transfer in cyto-
chrome c release, we tested the e¡ect of several respiratory
substrates on cytochrome c release in a cell free system. Mi-
tochondrial fraction from ML-1a was incubated in the pres-
ence of malate, glutamate, pyruvate (complex I substrates),
succinate (complex II substrate), K-glycerophosphate (com-
plex III substrate), ascorbate with N,N,NP,NP-tetramethyl-p-
phenylenediamine (TMPD) (complex IV substrate) and glu-
cose for 15 min at 37‡C. Respiratory activity of these sub-
Fig. 2. Respiratory function-dependent cytochrome c release by
TNF in vivo. A: ML-1a, clone 19, and P1 cells were incubated with
1 nM TNF in the presence of 1 Wg/ml CHX for 90 min. After the
cytosolic fraction was obtained, cytochrome c release from mito-
chondria was detected by Western blotting as described in Section
2. B: ML-1a was incubated with or without 1 nM TNF and 1 Wg/
ml CHX in the presence or absence of 10 WM rotenone or 0.25 mM
TTFA for 90 min, and cytochrome c release from mitochondria was
detected as described in Section 2.
Fig. 3. Cytochrome c release by respiratory substrates in vitro. Mi-
tochondrial fraction from ML-1a was incubated with substrates of
each complex and the released cytochrome c and oxygen consump-
tion were detected as described in Section 2.
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strates was also investigated. Of the complex I substrates,
malate is the most e¡ective for cytochrome c release and oxy-
gen consumption, glutamate is a weaker inducer of cyto-
chrome c release and oxygen consumption, and pyruvate is
a poor e¡ector. Complex II substrate succinate and complex
III substrate K-glycerophosphate were good inducers of cyto-
chrome c release and oxygen consumption. Addition of ascor-
bate/TMPD to mitochondrial fraction increased oxygen con-
sumption but failed to release cytochrome c. Glucose has a
slight e¡ect on both oxygen consumption and cytochrome c
release (Fig. 3). Substrates for complexes I, II, and III but not
IV released cytochrome c. Malate and glutamate reduce com-
plex I, coenzyme Q, complex III, cytochrome c and complex
IV; succinate reduces complex II, coenzyme Q, complex III,
cytochrome c and complex IV; K-glycerophosphate reduces
coenzyme Q, complex III, cytochrome c and complex IV;
and ascorbate/TMPD reduces cytochrome c and complex
IV. Therefore, reduction of coenzyme Q and/or complex III
might be necessary for cytochrome c release. Since this is one
of the most e¡ective sites to reduce an oxygen molecule and
generate ROS [24], ROS generation from this site might be
followed by cytochrome c release. Signi¢cant release of cyto-
chrome c by succinate was observed within a minute after
treatment, and then cytochrome c release increased in a
time-dependent fashion (Fig. 4A). In contrast, in the control,
we could not see any cytochrome c release up to 10 min, and
at 15 min, a small amount of cytochrome c release was ob-
served (Fig. 4A). Cytochrome c was released in a dose-depen-
dent fashion by succinate and a 20 mM succinate treatment
for 15 min released 70% of total mitochondrial cytochrome c
(Fig. 4B).
We investigated the mechanisms of how cytochrome c is
released from mitochondria after succinate, a complex II sub-
strate, treatment. One possible mechanism that releases cyto-
chrome c is the disruption of mitochondrial outer membrane,
which can be inhibited by overexpressing Bcl-xl [21]. We
tested whether the mitochondrial outer membrane is disrupted
by the ability of a much larger protein (160 kDa) to gain
access to the intermembrane space by using an antibody to
cytochrome c oxidase subunit IV after succinate and digitonin
treatment. Digitonin in a low concentration is known to dis-
rupt cellular membrane and mitochondrial outer membrane
but not the inner membrane [25]. As shown in Fig. 5A, con-
trol mitochondrial fraction and mitochondrial fraction treated
with succinate bound to the cytochrome c oxidase antibody to
the same extent. The failure of these samples to show speci¢c
staining suggests that the outer membrane is intact after suc-
cinate treatment. In contrast, there is enhanced and speci¢c
staining with the cytochrome c oxidase antibody to digitonin-
treated mitochondrial fraction.
Next, we investigated whether succinate treatment gener-
ated a pore size smaller than the antibody and larger than
cytochrome c (12 kDa). Mitochondrial fraction from ML-1a
was incubated with succinate or digitonin, and oxygen con-
sumption in the presence or absence of cytochrome c in the
bu¡er was measured by using ascorbate/TMPD, which can
reduce cytochrome c (Fig. 5B). As expected, oxygen consump-
tion of succinate-treated mitochondria was greatly reduced,
since cytochrome c was released by succinate treatment. The
addition of cytochrome c reversed the inhibition of oxygen
consumption, suggesting that added cytochrome c could pen-
etrate mitochondrial outer membrane and reduce complex IV
in the presence of ascorbate/TMPD. In contrast, inhibition of
oxygen consumption by digitonin was small and the e¡ect of
cytochrome c addition on ascorbate/TMPD-dependent oxygen
consumption in digitonin-treated mitochondria was compara-
ble to that in control mitochondria.
We also examined the release of cytochrome c from mito-
chondria by succinate and digitonin. Digitonin could release
cytochrome c, however, the amount of cytochrome c released
by digitonin was extremely smaller than that by succinate
(Fig. 5C). In conclusion, although disruption of the mitochon-
drial outer membrane can release cytochrome c by digitonin
treatment, initiation of respiration through complex II^III^IV
by succinate released considerably more cytochrome c without
disrupting the mitochondrial outer membrane.
Several mechanisms have been considered to release cyto-
chrome c from mitochondria. Several factors such as oxygen
concentration, coupling/uncoupling, the state of respiration,
the concentration of respiratory substrate, and antioxidants
can control ROS generation from mitochondria [26]. ROS
generation has been considered one of the causes of cyto-
chrome c release. Therefore, the increase in ROS generation
by the change of mitochondrial respiratory substrate might be
one of the causes for cytochrome c release.
Since family members of Bcl-2 work as anti- or pro-apo-
ptotic molecules and their structure bears striking resemblance
to diphtheria toxin which forms a channel to the membrane
[27], the formation of pores to the mitochondrial outer mem-
brane has been considered one of the causes of apoptosis. Fig.
5A,C indicates that disruption of mitochondrial outer mem-
brane alone is not su⁄cient and is not the cause of cyto-
chrome c release by succinate. These results indicate that cy-
tochrome c needs to be stabilized inside the outer membrane
under non-apoptotic condition.
One of the possible mechanisms, which can stabilize cyto-
chrome c, is the association of cytochrome c with the mito-
chondrial inner membrane. Cytochrome c is located on the
mitochondrial inner membrane, this association is dependent
on its interaction with acidic lipid cardiolipin and is regulated
by the redox state [28]. Generation of ROS from the coen-
zyme Q site might also regulate oxidation of cardiolipin and
a¡ect cytochrome c release. Furthermore, the stimulation of
oxidative metabolism induces the desorption of cytochrome c
pool from the inner membrane into the intermembrane space
Fig. 4. A: Time course of succinate-dependent cytochrome c release.
B: Dose response of succinate on cytochrome c release from and re-
maining in mitochondria. Mitochondrial fraction from ML-1a was
incubated with 5 mM (A) or the indicated amount (B) of succinate
for the indicated times (A) or 15 min (B) at 37‡C and the released
cytochrome c was detected by Western blotting as described in Sec-
tion 2.
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[29]. Therefore, the reduction of the MRC (possibly coenzyme
Q or complex III) by respiratory substrates increases the
amount of cytochrome c in the intermembrane space, over-
comes the stabilizing e¡ect located inside the outer membrane,
and ¢nally induces cytochrome c to penetrate the outer mem-
brane by unknown mechanisms. Even though we could not
detect the pore which enables anti-cytochrome c oxidase anti-
body to access the inner membrane from outside, cytochrome
Fig. 5. The e¡ect of succinate and digitonin on mitochondria for outer mitochondrial membrane disruption (A), for cytochrome c penetration
(B), and for cytochrome c release (C). Mitochondrial fraction from ML-1a was incubated with 10 mM succinate or 12 WM digitonin for 15 min
at 37‡C and washed. The binding to monoclonal antibody, to cytochrome c oxidase subunit IV or control antibody was determined as de-
scribed in Section 2 (A), oxygen consumption was determined in the absence or presence of 100 WM cytochrome c using ascorbate/TMPD as a
substrate as described in Section 2 (B), and cytochrome c release from mitochondrial fraction was detected by Western blotting as described in
Section 2 (C).
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c (molecular weight 12 kDa) which is added from outside of
the mitochondrial outer membrane can access the inner mem-
brane in succinate-treated mitochondria (Fig. 5B).
In addition, the hinge protein is very acidic, connects cyto-
chrome c1 and cytochrome c [30], and is reported to regulate
cytochrome c release leading to apoptosis [31]. We can spec-
ulate that the association of cytochrome c to the hinge protein
can be regulated by respiratory substrates and may a¡ect the
desorption of cytochrome c pool from the inner mitochondrial
membrane into the intermembrane space. In each case, cyto-
chrome c needs to penetrate the outer membrane, and such a
mechanism including the roles of ROS induced by respiratory
substrate is now under investigation.
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